Objectives Guidelines recommend against the use of Papanicolaou (Pap) or human
papillomavirus (HPV) testing when determining eligibility for the HPV vaccine. Optimally, the …

Human papillomavirus (HPV) vaccines prevent cervical pre-cancer lesion and can
potentially reduce abnormal Papanicolaou (Pap) results among vaccinated females …

Abstract Introduction In the United States, Federally Qualified Health Centers (FQHCs) are
safety-net clinics that provide cervical cancer screening and human papillomavirus (HPV) …

Background: US cervical cancer screening recommendations have not changed since the
human papillomavirus (HPV) vaccine introduction in 2006, but epidemiological and cost …

Background Expert recommendations do not recommend using Papanicolaou (Pap) or
human papillomavirus (HPV) test results to determine whether unvaccinated women should …

Objective To investigate the HPV testing recommendations of US physicians who perform
cervical cancer screening. Methods Data from the 2015 DocStyles survey of US health care …

Objectives The objective of this study was to determine the impact of Pap test compliance
and cervical cancer screening intervals on human papillomavirus (HPV) vaccination …

Abstract BACKGROUND: The Centers for Disease Control and Prevention recommends
catch‐up administration of human papillomavirus (HPV) vaccines to girls and women ages …

We examined factors potentially related to providers' selfreported human papillomavirus
vaccine administration to female Medicaid enrollees among providers who consistently …

Purpose Little is known about how the number of HPV vaccine doses affect adherence to
screening guidelines. This study compared adherence to cervical cancer screening by the …